AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT04464902

The Effects of Knee Extension Constraint Rehabilitation After ACL Reconstruction

A study testing brace1 and brace2 in people with Anterior Cruciate Ligament Injuries, run by Peking University Third Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To develop new prevention programs for non-contact ACL injuries that do not require additional training time and assistance from a sports medicine professional personnel. A knee extension constraint will be utilized to patients who have undertaken ACL reconstruction. Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
brace1 and brace2
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
28 Jul 2016to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients who have isolated ACL injury and receive ACL reconstruction surgery at Sports Medicine Center, 3rd Hospital of Beijing University, Beijing, China.
  • 18-35 years old
  • With isolated ACL injury (an ACL injury with no need for surgical repairs to other knee structures).
  • All participants have no known disorders or diseases other than ACL rupture.

Who cannot join

  • Female patients who are pregnant, or suspected pregnant, or in breastfeeding will be excluded from this study.

Trial locations and contacts

1 site in 1 country.

Yuanyuan Yu, Bachler contact

+8615201134356

YYY1091012@126.com

China1 site, 1 recruiting
  • Peking University Third Hospital

    Beijing, 100191

    Hongshi Huang, Doctor, 01082267565, huanghs@bjmu.edu.cn

    Recruiting

Other trials in China

About this study

To develop new prevention programs for non-contact ACL injuries that do not require additional training time and assistance from a sports medicine professional personnel. A knee extension constraint will be utilized to patients who have undertaken ACL reconstruction.

And to determine the effects of knee extension constraint rehabilitation on lower extremity biomechanics after ACL reconstruction surgery.

Read the detailed description

Purpose Of exploring the biomechanical effect of knee extension constraint rehabilitation on rehabilitation after anterior cruciate ligament (ACL) reconstruction. Methods: Recruit 60 patients after ACL reconstruction. Divide them into three groups by random block method: Knee extension constraint rehabilitation group (wearing a brace with limitation of knee extension), Placebo group (wearing a brace without limitation of knee extension), and Control group (no brace is worn). The three groups of patients received the same rehabilitation training from 1 to 12 weeks after surgery, starting from week 13 and intervening on the first day of each week (wearing braces). Five tests were performed at the end of the 12th, 24th, 36th, and 48th weeks after surgery. Vicon system and force platform system will be synchronized used to test walking, jogging, side-cutting, and jumping; The Isokinetic dynamometer system will be used to test muscle strength. Outcome evaluation indicators and statistical methods: (1) Mixed design two-way analysis of variances will be used for the following indicators: approach run velocity and jump height; knee flexion angle at initial foot contact with the ground; knee extension moment at the time of peak impact poster ground reaction force, study group will be considered as an independent variable while testing time as the variable for repeated measurements. (2) The knee flexion, valgus-varus, and internal-external rotation angles, and extension, valgus-varus, and internal-external rotation moments of each leg during support phase of each movement will be expressed as functions of normalized movement time and leg (involved or uninvolved) using regression analysis with dummy variable. A dummy variable will be used to represent involved and uninvolved legs. A forward elimination procedure will be used to determine the best regression equations. The regression procedure will be stopped when the contributions of powers of n+1 and n+2 have no significant contribution to the overall regression. The contribution of the dummy variable in the regression will be an indication of asymmetry of the movements of involved and uninvolved legs. The effect of study group on movement asymmetry will be determined by comparing the contribution of dummy variables to the overall regression among study groups using a one-way ANOVA. The effects of study group and testing time on the ACL injury risk index will be determined for each knee in each movement using two-way ANOVA with mixed model. Study group will be considered as an independent variable while testing time as a repeated measure variable.

Being tested
brace1, brace2, No Intervention
Keywords
anterior cruciate ligament, injury prevention, knee extension constraint
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • brace1Device

    The brace1 can provide resistance when patients want to extend their knee.

  • brace2Device

    The brace1 can't provide resistance when patients want to extend their knee.

  • No InterventionOther

    Control Group don't have any brace.

Study groups in NCT04464902
Study groupRoleWhat they receive
knee extension constraint rehabilitation groupOtherNot described
Receives: Device: brace1
placebo groupOtherNot described
Receives: Device: brace2
control groupOtherNot described
Receives: Other: No Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. walking speed

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 24 weeks after ACL reconstruction surgery.

  2. walking speed

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 36 weeks after ACL reconstruction surgery.

  3. walking speed

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 48 weeks after ACL reconstruction surgery.

  4. ground reaction force

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 24 weeks after ACL reconstruction surgery.

  5. ground reaction force

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 36 weeks after ACL reconstruction surgery.

  6. ground reaction force

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 48 weeks after ACL reconstruction surgery.

  7. knee flexion angle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 24 weeks after ACL reconstruction surgery.

  8. knee flexion angle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 36 weeks after ACL reconstruction surgery.

  9. knee flexion angle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 48 weeks after ACL reconstruction surgery.

  10. the moment of knee extension in the gait cycle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 24 weeks after ACL reconstruction surgery.

  11. the moment of knee extension in the gait cycle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 36 weeks after ACL reconstruction surgery.

  12. the moment of knee extension in the gait cycle

    Three-dimensional gait analysis system were used during walking, jogging, cutting and jumping.

    Measured: at 48 weeks after ACL reconstruction surgery.

Secondary outcomes (3)
  1. The International Knee Documentation Committee (IKDC) score

    The International Knee Documentation Committee (IKDC) score was used to evaluate the knee health.The patients completed score by themselves. The lowest score is 0 and the highest score is 100.

    Measured: at 24 weeks after ACL reconstruction surgery.

  2. The International Knee Documentation Committee (IKDC) score

    The International Knee Documentation Committee (IKDC) score was used to evaluate the knee health.The patients completed score by themselves. The lowest score is 0 and the highest score is 100.

    Measured: at 36 weeks after ACL reconstruction surgery.

  3. The International Knee Documentation Committee (IKDC) score

    The International Knee Documentation Committee (IKDC) score was used to evaluate the knee health.The patients completed score by themselves. The lowest score is 0 and the highest score is 100.

    Measured: at 48 weeks after ACL reconstruction surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2020
  2. Study start28 Jul 2016
  3. Primary completion30 Dec 2020 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04464902
Sponsor's protocol ID
IR001
Status last verified
Jun 2020
First submitted
30 Jun 2020
Last updated
9 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing brace1 and brace2 in people with Anterior Cruciate Ligament Injuries, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yuanyuan Yu, Bachler (+8615201134356, YYY1091012@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

walking speed (time frame: at 24 weeks after ACL reconstruction surgery.). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in